FOXD3 Human shRNA Plasmid Kit (Locus ID 27022)

SKU
TL312939
FOXD3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
  $1,013.00
In Stock*
Specifications
Specifications
Product Data
Locus ID 27022
Synonyms AIS1; Genesis; HFH2; VAMAS2
Vector pGFP-C-shLenti
E. coli Selection Chloramphenicol (34 ug/ml)
Mammalian Cell Selection Puromycin
Format Lentiviral plasmids
Components FOXD3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 27022). 5µg purified plasmid DNA per construct
29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free.
RefSeq NM_012183, NM_012183.1, NM_012183.2, BC172266, BC172572, NM_012183.3
UniProt ID Q9UJU5
Summary This gene belongs to the forkhead family of transcription factors which is characterized by a distinct forkhead domain. Mutations in this gene cause autoimmune susceptibility 1. provided by RefSeq, Nov 2008
shRNA Design These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Storage Store at -20°C
Shipping Ambient
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Activation of Tyrosine Metabolism in CD13+ Cancer Stem Cells Drives Relapse in Hepatocellular Carcinoma
Sun, Zhang, Chen et al
Cancer Res Treat (2020) 52 (2), 604-621 DOI: 10.4143/crt.2019.444
Cited by 49
AI Summary: OriGene products, specifically the anti-CD13 antibody (TA327322) and Foxd3 expression plasmid (RC206636), were used in this study to identify and manipulate CD13+ cancer stem cells and to analyze Foxd3 function, thereby enabling investigation of the molecular mechanisms underlying relapse in hepatocellular carcinoma.
FigureFigureFigure
Showing 1-1 of 1 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products